Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma

Journal of Clinical Oncology

Volumn 31, Issue 11, 2013, Pages

  Canaani, Jonathan ^a   Amit, Sharon ^a   Ben Ezra, Jonathan ^a   Pour, Mehrzad Cohen ^a   Sarid, Nadav ^a   Lerman, Hedva ^a   Perry, Chava ^a   Polliack, Aaron ^a   Naparstek, Elizabeth ^a   Herishanu, Yair ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETHAMBUTOL; ETOPOSIDE; IFOSFAMIDE; ISONIAZID; METHOTREXATE; OFLOXACIN; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LARGE CELL LYMPHOMA; LUNG TUBERCULOSIS; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTITUBERCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84876086403     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.6188     Document Type: Article

References (15)

1. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al: Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81:213-227, 2002 (Pubitemid 34507208)
2. Singh N, Lortholary O, Alexander BD, et al: An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 40:1756-1761, 2005 (Pubitemid 40799944)
3. Cheng VC, Yuen KY, Chan WM, et al: Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882-892, 2000 (Pubitemid 32250325)
4. Miceli MH, Maertens J, Buvé K, et al: Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer 110:112-120, 2007 (Pubitemid 46986424)
5. Cadena J, Thompson GR 3rd, Ho TT, et al: Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. Diagn Microbiol Infect Dis 64:327-330, 2009
6. Arend SM, Leyten EM, Franken WP, et al: A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 45:1470-1475, 2007 (Pubitemid 351411877)
7. Singh N, Perfect JR: Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45:1192-1199, 2007
8. van de Veerdonk FL, Lauwerys B, Marijnissen RJ, et al: The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 63:1507-1516, 2011
9. Iwata S, Saito K, Tokunaga M, et al: Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab. J Rheumatol 38:633-641, 2011
10. Sfikakis PP, Boletis JN, Lionaki S, et al: Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: An open-label trial. Arthritis Rheum 52:501-513, 2005 (Pubitemid 40216314)
11. Nagel A, Hertl M, Eming R: B-cell-directed therapy for inflammatory skin diseases. J Invest Dermatol 129:289-301, 2009
12. McDonald V, Leandro M: Rituximab in non-haematological disorders of adults and its mode of action. Br J Haematol 146:233-246, 2009
13. McLaughlin P, Hagemeister FB, Grillo-López AJ: Rituximab in indolent lymphoma: The single-agent pivotal trial. Semin Oncol 26:79-87, 1999 (Pubitemid 29523415)
14. Cho OH, Park KH, Kim T, et al: Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect 59:56-61, 2009
15. Garcia Vidal C, Rodríguez Fernández S, Martínez Lacasa J, et al: Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40:756-759, 2005